| People with institution matching "sanofi-aventis": Advanced Search | |||||
| Name | Institution | Area | Added by | Date | Mark D. Black (Info) | sanofi-aventis.com | Neuroscience | vmnaimoli | 2009‑03‑01 | Sim | Su Cheng (Info) | sanofi-aventis | lzhong1 | 2011‑02‑21 | Sim | Odile Fabre (Info) | University of Montpellier | Neurobiology, endocrinology | vmnaimoli | 2009‑06‑13 | Sim | Mark Geyer (Info) | UCSD | psychopharmacology | mtsai | 2007‑10‑08 | Sim | Stuart S. Licht (Info) | Novartis, MIT, sanofi-aventis | auerbach | 2012‑05‑09 | Sim | Vanessa M. Naimoli (Info) | sanofi-aventis | Neuroscience, psychopharmacology, latent inhibition, behavioral neuroscience, schizophrenia, MATRICS, neurodevelopment, anxiety, depression, circadian biology, immunity, comparative neuroscience | vmnaimoli | 2009‑03‑01 | Sim | Pascale M. Rabbah (Info) | sanofi-aventis | fnadim | 2009‑09‑29 | Sim | Miqin Robinson (Info) | Sanofi-Aventis Pharmaceuticals | dryugo | 2015‑03‑18 | Sim | Geoffrey Varty (Info) | sanofi-aventis | Neuroscience | vmnaimoli | 2009‑03‑01 | Sim | Ina Weiner (Info) | Tel Aviv University | Latent inhibition, animal models of schizophrenia, behavioral neuroscience | fritz | 2008‑04‑10 | Sim |
| Sign in to add a new person | |||||